Li Wang^1,2, Liping Zhang², Yi Yang^1,2,3

¹Biotherapy Center, ²Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China; ³School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China

Address correspondence to: Dr. Yi Yang, Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China. Tel: +86 371 66295420; E-mail: yiyang@zzu.edu. cn

Review Article |Published on: 31 March 2025

Gergely Jolles¹, Stephen Krivan², Eduardo Lopes Paolantonacci³, Phillipe Ouaja⁴

¹United St István and St Laszlo Hospital, Department of Pediatric Hematology and Stem Cell Transplantation, Budapest, Hungary; ²Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK; ³Hospital La Paz-IdiPAZ, Madrid, Spain; 4LFB Biotechnologies, Biopharmaceutical Direction, Courtaboeuf, France

Adress correspondence to: Dr. Gergely Jolles, United St István and St Laszlo Hospital, Dept. of Pediatric Hematology and Stem Cell Transplantation, Budapest, Hungary. Tel: +36309430260; Fax:+3614556226; E-mail: kriyang@hu.inter.net

Review Article |Published on: 31 March 2025